Medtronic: Study shows InterStim neurostim device helps overactive bladder

October 4, 2012 by MassDevice staff

Medtronic says a study of its InterStim neurostimulation device shows it's better than medication alone for treating less-severe overactive bladder syndrome.

Medtronic

Medtronic (NYSE:MDT) is touting positive results from a study of its InterStim sacral nerve stimulator for treating less-severe overactive bladder syndrome, saying the device produces "superior efficacy and quality of life" compared with medication alone.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp